RIGL

RIGL Other Income/Expenses (Net)

-$1.47MTTM · USD

Period ending:

RIGL FY Other Income/Expenses (Net)USD
RIGL FY Other Income/Expenses (Net)1999-12-31: $0.002000-12-31: $145.00K2001-12-31: $1.16M2002-12-31: -$14.00K2003-12-31: -$370.00K2004-12-31: $612.00K2005-12-31: $2.67M2006-12-31: $5.41M2007-12-31: $5.26M2008-12-31: $4.28M2009-12-31: $397.00K2010-12-31: $2.57M2011-12-31: $395.00K2012-12-31: $537.00K2013-12-31: $442.00K2014-12-31: $341.00K2015-12-31: $279.00K2016-12-31: $525.00K2017-12-31: $1.62M2018-12-31: $2.20M2019-12-31: $2.20M2020-12-31: -$771.00K2021-12-31: -$4.81M2022-12-31: -$3.02M2023-12-31: -$4.60M2024-12-31: -$5.83M2025-12-31: -$3.64M$5.41M-$5.83M
1999-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

RIGL other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 27 observations from Dec 31, 1999 to Dec 31, 2025.

Rigel Pharmaceuticals Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
-3,639,000
-5,826,000
-4,600,000
-3,023,000
-4,813,000
-771,000
2,197,000
2,203,000
1,624,000
525,000
279,000
341,000
442,000
537,000
395,000
2,573,000
397,000
4,279,000
5,255,000
5,410,000
2,666,000
612,000
-370,000
-14,000
1,155,000
145,000
0

Compare other income/expenses (net)

All RIGL financial metrics · RIGL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.